Filing Details

Accession Number:
0001209191-14-011263
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-02-18 16:03:27
Reporting Period:
2014-02-18
Filing Date:
2014-02-18
Accepted Time:
2014-02-18 16:03:27
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1125345 Macrogenics Inc MGNX Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1207833 L Arnold Oronsky C/O Macrogenics, Inc.
9640 Medical Center Drive
Rockville MD 20850
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2014-02-18 200,000 $36.50 1,708,716 No 4 S Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect See Footnote
Footnotes
  1. These securities were sold as follows: 192,940 by InterWest Partners VIII, LP ("IW8"), 1,540 by InterWest Investors VIII, LP ("II8") and 5,520 by InterWest Investors Q VIII, LP ("IIQ8"). InterWest Management Partners VIII, LLC ("IMP8") is the General Partner of IW8, II8 and IIQ8 and has sole voting and investment control over the shares owned by IW8, II8 and IIQ8. Arnold Oronsky is a Managing Directors of IMP8.
  2. The shares are held as follows: 1,648,219 by IW8; 13,262 by II8; and 47,235 by IIQ8. Arnold Oronsky disclaims beneficial ownership of these securities except to the extent of any pecuniary interest therein.